Literature DB >> 23218089

Olmesartan and intestinal adverse effects in the ROADMAP study.

Jan Menne, Hermann Haller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23218089      PMCID： PMC3547579          DOI： 10.1016/j.mayocp.2012.10.005

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  3 in total

1.  Severe spruelike enteropathy associated with olmesartan.

Authors:  Alberto Rubio-Tapia; Margot L Herman; Jonas F Ludvigsson; Darlene G Kelly; Thomas F Mangan; Tsung-Teh Wu; Joseph A Murray
Journal:  Mayo Clin Proc       Date:  2012-06-22       Impact factor: 7.616

2.  Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Authors:  Hermann Haller; Gian C Viberti; Albert Mimran; Giuseppe Remuzzi; Antonius J Rabelink; Eberhard Ritz; Lars C Rump; Luis M Ruilope; Shigehiro Katayama; Sadayoshi Ito; Joseph L Izzo; Andrzej Januszewicz
Journal:  J Hypertens       Date:  2006-02       Impact factor: 4.844

3.  Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.

Authors:  Hermann Haller; Sadayoshi Ito; Joseph L Izzo; Andrzej Januszewicz; Shigehiro Katayama; Jan Menne; Albert Mimran; Ton J Rabelink; Eberhard Ritz; Luis M Ruilope; Lars C Rump; Giancarlo Viberti
Journal:  N Engl J Med       Date:  2011-03-10       Impact factor: 91.245
  3 in total
  6 in total

1.  Blockers of Angiotensin Other Than Olmesartan in Patients With Villous Atrophy: A Nationwide Case-Control Study.

Authors:  Karl Mårild; Benjamin Lebwohl; Peter H R Green; Joseph A Murray; Jonas F Ludvigsson
Journal:  Mayo Clin Proc       Date:  2015-06       Impact factor: 7.616

2.  Olmesartan, other antihypertensives, and chronic diarrhea among patients undergoing endoscopic procedures: a case-control study.

Authors:  Ruby Greywoode; Eric D Braunstein; Carolina Arguelles-Grande; Peter H R Green; Benjamin Lebwohl
Journal:  Mayo Clin Proc       Date:  2014-07-11       Impact factor: 7.616

Review 3.  Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.

Authors:  René R Wenzel; Christian Datz
Journal:  Wien Klin Wochenschr       Date:  2019-08-30       Impact factor: 1.704

4.  [Three cases of severe chronic diarrhea with a rare cause and a simple therapy].

Authors:  K-P Rommel; E Schneider; I Witschel; U Halm; M Zachäus
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

5.  Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy.

Authors:  Peter Malfertheiner; Claudio Ripellino; Nazarena Cataldo
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-19       Impact factor: 2.890

6.  Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.

Authors:  Sripriya Gonakoti; Sanjiv Khullar; Aarthi Rajkumar
Journal:  Am J Case Rep       Date:  2019-01-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.